top of page
Woman & Doctor

ENCLEAR THERAPIES

Extending the lives of patients suffering from CNS disease

At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business utilizing our proprietary EnTrega CSF Platform to create a pipeline of significant near-term, patient focused, opportunities. Launching into neuro-oncology, while leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.

Institutional Partners

wMMI4l8xCdVPboHpnIR9yUpfZu01566910559408_200x200.png
partners-investors-logo-amgen.png
DolbyFamilyVentures-logo-horizontal-color-box-M-white.jpeg
presight.png
Quark_logo.png
2020_logo_Full_19.png

ABOUT ENCLEAR

Our mission is to improve and extend the lives of patients suffering from central nervous system (CNS) disorders such as neurodegenerative diseases and CNS malignancies.

​

Our opportunity is to utilize our EnTrega CSF Platform to provide precision dosing to areas of the CNS most benefited by both existing & next-generation therapeutics.

​

Our strategy is two-fold:

1) Launch into neuro oncology, immediately addressing $1.2B market need. 

2) Leverage partnerships to expand our portfolio with next gen, personalized medicine into neurodegenerative, lysosomal storage & autoimmune diseases.

EnTrega CSF PLATFORM

Closed loop CSF control & integrated ML/AI, the EnClear Therapies EnTrega CSF platform provides Precision Dosing of CNS based therapeutics to obtain efficacious levels, while reducing risk of severe side effects and peripheral toxicity.

Brain Scans

©2021 by EnClear Therapies.

bottom of page